PC7/8 Activators
PC7/8 Activators represents a group of compounds that have the capacity to influence the activation or function of proprotein convertase subtilisin/kexin type 7 and 8 (PCSK7 and PCSK8), also known as PCSK7/8. These enzymes play pivotal roles in the regulation of cholesterol metabolism within the body. While the specific activation mechanisms and compounds associated with this class may not be extensively detailed, it is important to understand the broader context in which these activators operate. PCSK7 and PCSK8 are part of the proprotein convertase family, encompassing enzymes that are responsible for the proteolytic processing and activation of various precursor proteins.
The term PC7/8 Activators implies a group of molecules or chemical entities that, by interacting with PCSK7 and PCSK8 or the pathways they are involved in, have the potential to influence their enzymatic activity or expression. These activators may act directly on the enzymes themselves, modulating their activity in a manner that could impact cholesterol metabolism, cellular signaling, or other related processes. Alternatively, they may affect pathways and cellular components upstream or downstream of PCSK7/8, indirectly altering the enzymes' activation or regulation. Understanding and harnessing the mechanisms by which these activators work can provide valuable insights into the intricate network of cellular processes related to cholesterol homeostasis and potentially offer opportunities for further research and exploration in the field of lipid metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, a statin drug, indirectly activates PCSK7 by inhibiting HMG-CoA reductase, a key enzyme in cholesterol biosynthesis, which in turn activates PCSK7. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin, another statin, indirectly activates PCSK7 by inhibiting cholesterol synthesis through HMG-CoA reductase inhibition. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Rosuvastatin is a potent statin that indirectly activates PCSK7 by lowering LDL cholesterol levels, which can impact the activation of PCSK7. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
Cholestyramine indirectly activates PCSK7 by binding to bile acids in the intestine, which prompts the liver to use more cholesterol for bile acid synthesis, potentially regulating PCSK7 activity. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate indirectly activates PCSK7 by reducing triglycerides and increasing HDL cholesterol, impacting overall cholesterol balance and potentially influencing PCSK7 function. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Ezetimibe indirectly activates PCSK7 by inhibiting cholesterol absorption in the intestine, which can impact the cholesterol levels that PCSK7 activates. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Niacin may indirectly activate PCSK7 by increasing HDL cholesterol levels and reducing LDL cholesterol, potentially impacting PCSK7-regulated cholesterol metabolism. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, an active compound in turmeric, may indirectly activate PCSK7 by potentially modulating cholesterol metabolism, although the exact mechanism remains to be fully elucidated. | ||||||